|
Sections |
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 8 |
| 1.1 List of Tables | 7 | 2 |
| 1.2 List of Figures | 9 | 1 |
| 2 Introduction | 10 | 1 |
| 2.1 What Is This Report About? | 10 | 1 |
| 3 Definitions of Markets Covered in This Report | 11 | 1 |
| 3.1 Drug delivery devices | 11 | 1 |
| 3.2 Needle-free Injections | 11 | 1 |
| 3.3 Inhalation Systems | 11 | 1 |
| 3.4 Infusion Systems | 11 | 1 |
| 4 Drug Delivery Devices in North America | 12 | 8 |
| 4.1 Drug Delivery Devices, North America, Overall Revenue ($ mn), 2000-2015 | 12 | 4 |
| 4.2 Drug Delivery Devices, North America, Category Volume (Units), 2000-2015 | 16 | 3 |
| 4.3 Drug Delivery Devices, North America, Company Share (2007-2008) | 19 | 1 |
| 5 Drug Delivery Devices In United States | 20 | 12 |
| 5.1 Drug Delivery Devices, United States, Overall Revenue ($ mn), 2000-2015 | 20 | 3 |
| 5.2 Drug Delivery Devices, United States, Category Volume (Units), 2000-2015 | 23 | 3 |
| 5.3 Drug Delivery Devices, United States, Distribution Share (2007-2008) | 26 | 1 |
| 5.3.1 Infusion Systems Distribution Share (2007-2008) | 26 | 1 |
| 5.3.2 Inhalation Systems Distribution Share (2007-2008) | 26 | 1 |
| 5.3.3 Needle Free Injections Distribution Share (2007-2008) | 27 | 1 |
| 5.4 Drug Delivery Devices, United States, Company Share (2007-2008) | 28 | 1 |
| 5.4.1 Drug Delivery Devices, United States, Company Share (2007-2008) | 28 | 1 |
| 5.4.2 Infusion Systems, United States, Company Share (2007-2008) | 29 | 1 |
| 5.4.3 Inhalation Systems, United States, Company Share (2007-2008) | 30 | 1 |
| 5.4.4 Needle Free Injections, United States, Company Share (2007-2008) | 31 | 1 |
| 6 Drug Delivery Devices In Canada | 32 | 12 |
| 6.1 Drug Delivery Devices, Canada, Overall Revenue ($ mn), 2000-2015 | 32 | 3 |
| 6.2 Drug Delivery Devices, Canada, Category Volume (Units), 2000-2015 | 35 | 3 |
| 6.3 Drug Delivery Devices, Canada, Distribution Share (2007-2008) | 38 | 1 |
| 6.3.1 Infusion Systems Distribution Share (2007-2008) | 38 | 1 |
| 6.3.2 Inhalation Systems Distribution Share (2007-2008) | 38 | 1 |
| 6.3.3 Needle Free Injections Distribution Share (2007-2008) | 39 | 1 |
| 6.4 Drug Delivery Devices, Canada, Company Share (2007-2008) | 40 | 1 |
| 6.4.1 Drug Delivery Devices, Canada, Company Share (2007-2008) | 40 | 1 |
| 6.4.2 Infusion Systems, Canada, Company Share (2007-2008) | 41 | 1 |
| 6.4.3 Inhalation Systems, Canada, Company Share (2007-2008) | 42 | 1 |
| 6.4.4 Needle Free Injections, Canada, Company Share (2007-2008) | 43 | 1 |
| 7 Overview of Key Companies in North America Drug Delivery Devices Market | 44 | 15 |
| 7.1 AstraZeneca PLC | 44 | 1 |
| 7.1.1 Company Overview | 44 | 1 |
| 7.2.1 Company Overview | 44 | 1 |
| 7.3.1 Company Overview | 45 | 1 |
| 7.4 Boehringer Ingelheim GmbH | 45 | 1 |
| 7.4.1 Company Overview | 45 | 1 |
| 7.5 Baxter International Inc. | 46 | 1 |
| 7.5.1 Company Overview | 46 | 1 |
| 7.6.1 Company Overview | 46 | 1 |
| 7.7 Terumo Corporation | 47 | 1 |
| 7.7.1 Company Overview | 47 | 1 |
| 7.7.2 Terumo Corporation Pipeline Products | 47 | 1 |
| 7.7.2.1 Terumo Corporation Pipeline Products By Equipment Type | 47 | 1 |
| 7.7.2.2 Terumo Corporation Pipeline Products By Development Stage | 47 | 1 |
| 7.7.2.3 Terumo Corporation Pipeline Products By Therapy Area | 48 | 1 |
| 7.7.2.4 Terumo Corporation Pipeline Products By Clinical Trials | 48 | 1 |
| 7.7.2.5 Terumo Corporation Pipeline Products By News Summary | 49 | 1 |
| 7.8 Cardinal Health, Inc. | 50 | 1 |
| 7.8.1 Company Overview | 50 | 1 |
| 7.9 GlaxoSmithKline plc | 51 | 1 |
| 7.9.1 Company Overview | 51 | 1 |
| 7.10 B. Braun Melsungen AG | 52 | 1 |
| 7.10.1 Company Overview | 52 | 1 |
| 7.11 Smiths Medical | 52 | 1 |
| 7.11.1 Company Overview | 52 | 1 |
| 7.12 Fresenius Kabi AG | 53 | 1 |
| 7.12.1 Company Overview | 53 | 1 |
| 7.13 Bioject Medical Technologies Inc. | 54 | 1 |
| 7.13.1 Company Overview | 54 | 1 |
| 7.13.2 Bioject Medical Technologies Inc. Pipeline Products | 54 | 1 |
| 7.13.2.1 Bioject Medical Technologies Inc. Pipeline Products By Equipment Type | 54 | 1 |
| 7.13.2.2 Bioject Medical Technologies Inc. Pipeline Products By Development Stage | 54 | 1 |
| 7.13.2.3 Bioject Medical Technologies Inc. Pipeline Products By Therapy Area | 55 | 1 |
| 7.13.2.4 Bioject Medical Technologies Inc. Pipeline Products By Clinical Trials | 55 | 1 |
| 7.13.2.5 Bioject Medical Technologies Inc. Pipeline Products By News Summary | 55 | 1 |
| 7.14 Consort Medical plc | 56 | 1 |
| 7.14.1 Company Overview | 56 | 1 |
| 7.14.2 Consort Medical plc Pipeline Products | 56 | 1 |
| 7.14.2.1 Bespak plc Pipeline Products By Equipment Type | 56 | 1 |
| 7.14.2.2 Bespak plc Pipeline Products By Development Stage | 56 | 1 |
| 7.14.2.3 Bespak plc Pipeline Products By Therapy Area | 57 | 1 |
| 7.15 Hospira, Inc. | 58 | 1 |
| 8 Financial Deals Landscape | 59 | 17 |
| 9 Recent Developments | 76 | 13 |
| 9.1 Strategy and Business Planning | 76 | 1 |
| 9.1.1 Sep 02, 2009: Generex Launches European Subsidiary | 76 | 1 |
| 9.1.2 Jul 10, 2009: Cardinal Health Board Approves CareFusion Spinoff | 76 | 1 |
| 9.1.3 May 18, 2009: MEI And GE Healthcare Sign Strategic Agreement | 77 | 1 |
| 9.1.4 Mar 24, 2009: Hospira Announces Plans To Optimize Operations, Increase Shareholder Value | 77 | 1 |
| 9.2 Legal and Regulatory | 78 | 1 |
| 9.2.2 Jul 29, 2009: Kendall Law Group Files Class Action Suit Against Genzyme | 79 | 1 |
| 9.2.3 May 27, 2009: Verus Pharmaceuticals Files Lawsuit Against AstraZeneca and Tika | 79 | 1 |
| 9.2.4 May 21, 2009: QLT Announces Court Response To Motion To Dismiss And Removal Of Case To Federal Court | 79 | 1 |
| 9.2.5 May 18, 2009: Corium Fentanyl Patch Plant Is Slapped With A Form 483 | 80 | 1 |
| 9.2.6 Apr 07, 2009: Mallinckrodt Sues Two Bracco Units Over Patent-Infringement | 80 | 1 |
| 9.2.7 Mar 11, 2009: Akela Pharma Announces Settlement Agreement In Lab Research Litigation | 80 | 1 |
| 9.3 Government and Public Interest | 81 | 1 |
| 9.3.1 Jul 29, 2009: Drug Delivery Via Prototype Contact Lenses | 81 | 1 |
| 9.3.2 Mar 10, 2009: Risk Of Burns During MRI Scans From Transdermal Drug Patches With Metallic Backings | 81 | 1 |
| 9.4 Product News | 82 | 1 |
| 9.4.1 Jun 25, 2009: Maximus Presents MaxPlus Clear At Infusion Nursing Society Annual Conference | 82 | 1 |
| 9.4.2 Jun 09, 2009: Greyson International Announces Safety Study Results Of Trilexon System | 83 | 1 |
| 9.4.3 Jun 08, 2009: Delcath Systems Completes Seventy Five Percent Patient Enrollment In Pivotal Phase III Metastatic Melanoma Clinical Trial | 83 | 1 |
| 9.4.4 Jun 08, 2009: MannKind Initiates Development Of Next-Generation Inhalation System To Enhance Delivery Of Drug Powders | 84 | 1 |
| 9.4.5 Apr 21, 2009: Greyson Announces Trademark Approval For Trilexon System | 84 | 1 |
| 9.4.6 Apr 17, 2009: Optinose Presents New Data Of Nasal Drug Delivery Device With fluticasone For The Treatment Of Chronic Rhinosinusitis | 84 | 1 |
| 9.4.7 Apr 10, 2009: Delcath Announces Expansion Of Clinical Trial Centers To Test PHP System | 85 | 1 |
| 9.4.8 Apr 04, 2009: Bioject Medical Technologies Receives US FDA Approval To Market Zetajet Needle-Free Injection Therapy System | 85 | 1 |
| 9.4.10 Mar 10, 2009: Vyteris Announces Phase II Clinical Trial Commencement Of Smart Patch Technology For Infertility Treatment | 86 | 1 |
| 9.4.11 Jan 19, 2009: AeonClad Biomedical Utilizes AeonCoat Technology To the Drug Delivery And Medical Devices Markets | 87 | 1 |
| 9.4.12 Jan 15, 2009: Teva Specialty Pharmaceuticals Donates ProAir HFA To Direct Relief International Help Economically Disadvantaged Asthma Sufferers Breathe Easier | 87 | 1 |
| 9.4.13 Jan 08, 2009: Medegen Announces 510(k) Clearance For MaxGuard Advanced Luer-Activated Device With Antimicrobial Technology | 88 | 1 |
| 10 Appendix | 89 | 5 |
| 10.1 Global Markets Direct Research Methodology | 89 | 1 |
| 10.2 Secondary Research | 90 | 1 |
| 10.3 Primary Research | 90 | 1 |
| 10.4 Models | 91 | 1 |
| 10.5 Forecasts | 91 | 1 |
| 10.6 Expert Panel Validation | 91 | 1 |
| 10.7 Currency Conversion | 92 | 1 |
| 10.8 Contact Us | 93 | 1 |
| 10.9 Disclaimer | 93 | 1 |
